Skip to main content
News Icon

Honors & Funding

6 Cluster member among Highly Cited Researcher

With a total of 14 researchers, the University of Bonn is represented this year in the international ranking of "Highly Cited Researchers". Among them are 6 scientists from the Cluster of Excellence ImmunoSensation.

According to the creators of the ranking, the persons on this list of "Highly Cited Researchers" belong to the most influential one percent of their field worldwide. The benchmark is the frequency with which their scientific publications were cited by other researchers in the past decade (period from 2009 to 2019). The ranking is published annually by the "Web of Science Group" and contains around 6,200 scientists in 21 subject categories.

Following members of ImmunoSensation are named 'Highly Cited Researcher':

Monique M. B. Breteler
Michael T. Heneka
Eicke Latz
Mihai G. Netea
Joachim L. Schultze
Andreas Schlitzer

Related news

Niklas Klümper

Honors & Funding

Niklas Klümper Receives Johann-Georg-Zimmermann Prize

—PD Dr. Niklas Klümper was honored with the prestigious Johann-Georg-Zimmermann Research Prize. The €10,000 award is presented annually to young cancer researchers for their current scientific contributions.
View entry
Speakers of ImmunoSensation

Honors & Funding

ImmunoSensation goes into the next round

—The Bonn Cluster of Excellence ImmunoSensation will be funded for further seven years as part of the Excellence Strategy of the German federal and state governments. The aim of the new funding period, which begins on January 1, 2026, is to research immune diversity: the structural, functional and dynamic diversity of the immune system. Involved are the University of Bonn, the University Hospital Bonn (UKB) and the German Center for Neurodegenerative Diseases (DZNE). The funding amounts to around 50 million euros.
View entry
Kerstin Ludwig

Honors & Funding

Genome data to improve diagnosis and treatment of long Covid

—Despite the many advances, there are still major gaps in the care of patients with long-term and post-COVID. The Institute of Human Genetics at the UKB in Bonn now begins a genomLC study as part of a BMG funding priority. The researchers want to help speed up the diagnosis of long- and post-COVID and identify possible biomarkers that could possibly also differentiate between subgroups of the diseases. To this end, the genomic data of those affected is being analyzed as part of a study using blood samples. The project is funded by the Federal Ministry of Health (BMG) with 1.34 million euros.
View entry

Back to the news overview